Here are relevant reports on : aortic-stent-graft-market
-
Vascular Stent Market by Technology (Drug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029
The global vascular stents market, valued at US$10.7 billion in 2023, stood at US$11.4 billion in 2024 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2029, culminating in a forecasted valuation of US$15.6 billion by the end of the period. The growth of the vascular stents market is primarily attributed to the increasing incidence of vascular diseases (such as coronary artery diseases, peripheral artery diseases, and endovascular aortic aneurysms) and the rising uptake of angioplasty procedures.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022
The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Dental Bone Graft Substitutes Market by Type (Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region - Global Forecast to 2031
The global dental bone graft substitutes market is projected to reach USD 1.01 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Angioplasty Stent, Catheters (IVUS/OCT), Plaque Modification, Vascular Closure Devices, Balloon Inflation Devices, Hemodynamic Flow Alteration), End User - Global Forecast to 2031
The global peripheral vascular devices market, valued at USD 9.55 billion in 2025, stood at USD10.02 billion in 2026 and is projected to advance at a resilient CAGR of 5.7% from 2026 to 2031, culminating in a forecasted valuation of USD13.22 billion by the end of the period. The market for peripheral vascular devices is anticipated to grow due to several factors, including the rising incidence of peripheral artery disease and diabetes, an increasingly aging global population, and a preference for minimally invasive endovascular procedures that reduce hospital stays and recovery times.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030
The global biosurgery market, valued at US$14.96 billion in 2024, stood at US$15.83 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026
The global ERCP market in terms of revenue was estimated to be worth $1.3 billion in 2021 and is poised to reach $2.0 billion by 2026, growing at a CAGR of 9.6% from 2021 to 2026. The drivers of the market include the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, a growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries.
- Published: March 2022
- Price: $ 4950
- TOC Available:
-
Vascular Graft Market by Indication (EVAR, Abdominal Aneurysm Repair, Thoracic Aneurysm, Peripheral Vascular Repair), Raw Material (Polyester, ePTFE, Polyurethane, Biosynthetic), End Users (Hospital, Ambulatory Surgery Center) & Region
The global vascular grafts market is expected to grow at a CAGR of 7.3%. Growth in the vascular grafts market is mainly driven by the constant growth in the geriatric population and the corresponding prevalence of aneurysms, increasing incidence of end-stage renal disease, and the growing preference for minimally invasive surgeries. Key players operating in this market are B. Braun (Germany), C. R. Bard (US), Cardinal Health (US), Cook Medical (US), Endologix (US), LeMaitre Vascular (US), Medtronic (Ireland), Maquet (Germany), Terumo (Japan), and Gore Medical (US).
- Published: January 2018
- Price: $ 4950
- TOC Available:
-
Orthopedic Devices Market by Product (Fixation, Replacement, Prosthetics, Spinal Implant, Brace, Orthobiologics (DBM), Bone Graft), Procedures Volume (Knee, Hip, Ankle, Shoulder) Site, Application, End User (Hospital, ASC, Trauma) - Global Forecast to 2030
The global orthopedic devices market, valued at US$49.63 billion in 2023, stood at US$51.61 billion in 2024 and is projected to advance at a resilient CAGR of 4.8% from 2024 to 2030, culminating in a forecasted valuation of US$68.51 billion by the end of the period. The primary driver of the market is the increasing prevalence of orthopedic disorders, especially in the geriatric population. The growth is also propelled by efforts by the market leaders in terms of new product launches for orthopedic devices.
- Published: March 2025
- Price: $ 12000
- TOC Available:
-
Craniomaxillofacial Implants Market by Type (Mid Face, Plates, Screws, Mandibular Orthognathic Implants, Neuro, Mesh, Bone Graft, Dural Repair), by Material of Construction (Titanium, Polymer), by Application Site & Property - Global Forecast to 2021
The global Craniomaxillofacial implants market size is projected to grow at a CAGR of 6.9%. The market is broadly classified into type, application site, material of construction, property and regions.
- Published: May 2016
- Price: $ 4950
- TOC Available:
-
Neurovascular Devices Market Size by Disease Pathology (Cerebral Aneurysm (Embolic coils, Flow Diverters), Ischemic Stroke (Clot Retriever, Aspiration, Snare), Carotid Stenosis (Stent, Embolic Protection), Others), End User (Hospitals) - Global Forecast to 2030
The global neurovascular devices market, valued at US$4.27 billion in 2024, stood at US$4.64 billion in 2025 and is projected to advance at a resilient CAGR of 9.3% from 2024 to 2030, culminating in a forecasted valuation of US$7.22 billion by the end of the period. The market growth is primarily driven by the prevalence of neurovascular diseases, influenced by factors such as aging populations, hypertension, smoking, and sedentary lifestyles.
- Published: November 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
